Steve Bryson is a science writer for Pulmonary Hypertension News with a PhD in biochemistry. He covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
Three months of CS1 therapy boosted quality of life, while symptoms tied to heart failure and clinical worsening and mortality risk declined.| Pulmonary Hypertension News
After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in PH-ILD patients.| Pulmonary Hypertension News
Low-dose metformin delivered to the pulmonary arteries using lipid-based nanocapsules, safely eased signs of PAH in rats.| Pulmonary Hypertension News
Category archive page for News.| Pulmonary Hypertension News
